Inhibition of RUNX1 slows the progression of pulmonary hypertension by targeting CBX5. Biomol Biomed [Internet]. 2024 Aug. 16 [cited 2025 Nov. 3];25(2):472–481. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/10720